Literature DB >> 12477185

Differential pulse voltammetric assay of lercanidipine in tablets.

Alejandro Alvarez-Lueje1, Sara Pujol, Luis J Núñez-Vergara, Juan A Squella.   

Abstract

Lercanidipine in ethanol-0.04M Britton-Robinson buffer (20 + 80) gives an irreversible anodic response on a glassy carbon electrode in a broad pH range (2-12) that depends on pH. This signal can be attributed to oxidation of the 1,4-dihydropyridine ring to give the corresponding pyridine derivative. For analytical purposes, differential pulse voltammetry at pH 4 was selected. Under these conditions, good values of both within- and interday reproducibility were obtained, with coefficient of variation (CV) values of 1.56 and 1.70%, respectively, for 10 successive runs. For quantitation, the calibration curve method was used for lercanidipine concentrations ranging from 1 x 10(-5) to 1 x 10(-4) M. The detection and quantitation limits were 1.39 x 10(-5) and 1.49 x 10(-5), respectively. A liquid chromatographic method with electrochemical detection was used for comparison. The voltammetric method showed good selectivity with respect to both excipients and degradation products. The recovery study exhibited a CV of 0.94% and an average recovery of 98.3%, and it was not necessary to treat the sample before the analysis. The method was successfully applied to the individual tablet assay of lercanidipine in commercial tablets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12477185

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  2 in total

1.  A fast, stability-indicating, and validated liquid chromatography method for the purity control of lercanidipine hydrochloride in tablet dosage form.

Authors:  Saumil Mehta; Sukhdev Singh; Kishor Chikhalia
Journal:  Sci Pharm       Date:  2014-01-16

2.  Spectrophotometric determination of labetalol and lercanidipine in pure form and in pharmaceutical preparations using ferric-1,10-phenanthroline.

Authors:  M A Abu El-Enin; D R El-Wasseef; D T El-Sherbiny; S M El-Ashry
Journal:  Int J Biomed Sci       Date:  2009-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.